Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Clinical trial NCT00382798 · COMPLETED

Trial details

NCT number: NCT00382798
Sponsor: Pharmasset
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Hepatitis C Virus

Start date: 2006-10-01
Primary completion: 2008-09-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.